Under cancer conditions, hnRNPA2/B1 and its downstream mediators PI3K/Akt/mTOR and JAK/STAT3 play important roles in inhibiting the release of apoptotic factors and cell proliferation [16,17]. Here, HNRNPA2B1 is linked to cancer.